Cooper Companies | COO - Fremdkapital





Fremdkapital Veränderung Datum
Abbott USD 29.64B 19.74B 2026-03
Align Technology USD 0 0 2024-12
AtriCure USD 61M 0 2026-06
Bausch Health Companies USD 19.88B 20M 2026-06
Baxter International USD 8.62B 6M 2026-06
Bayer EUR 31.16B 480M 2026-06
Becton, Dickinson and Co. USD 13.51B 1.2B 2026-06
Boston Scientific USD 10.86B 148M 2026-03
Cooper Companies USD 1.86B 17.7M 2026-03
Dentsply International USD 2B 10M 2026-06
Dexcom USD 1.3B 200K 2026-06
Edwards Lifesciences USD 598.7M 1.3M 2026-06
Globus Medical USD 398K 38K 2026-03
Haemonetics USD 1.17B 50.36M 2026-06
Inogen USD 0 0 2022-06
Insulet USD 929.5M 0 2026-06
Integra LifeSciences USD 1.83B 2.05M 2026-06
Intuitive Surgical USD 0 0 2025-03
J&J USD 37.34B 183M 2026-06
Medtronic USD 27.88B 255M 2025-12
Merit Medical Systems USD 736.26M 1.1M 2026-06
Novartis USD 37.45B 7.86B 2026-03
ResMed USD 399.42M 4.75M 2026-06
STAAR Surgical USD 42K 42K 2023-12
Steris USD 1.65B 162.6M 2026-06
Stryker USD 14.19B 32M 2026-06
Tandem Diabetes Care USD 602.58M 809K 2026-06
Teleflex USD 2.72B 206.24M 2026-06
Utah Medical Products USD 0 0 2022-03
Zimmer Biomet Holdings USD 6.28B 17.6M 2026-06